Atlas Trials

Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs

Clinical trial NCT04638868 · UNKNOWN

Trial details

NCT number
NCT04638868
Sponsor
Singapore General Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2020-11-17
Primary completion
2021-12-31
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.